Selected research
Market Structure
Global Viral Vector CTDMO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Viral Vector CTDMO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Viral Vector CTDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Viral Vector CTDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Viral Vector CTDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Viral Vector CTDMO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Viral Vector CTDMO Services include AGC Biologics, Lonza, Charles River Laboratories, Thermo Fisher Scientific, SK pharmteco, Batavia Biosciences, HALIX, Catalent Biologics and Oxford BioMedica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Viral Vector CTDMO Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Viral Vector CTDMO Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Viral Vector CTDMO Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Viral Vector CTDMO Services market size, projected growth trends, production technologies, key applications, and end-use industries.
Viral Vector CTDMO Services Segment by Company
AGC Biologics
Lonza
Charles River Laboratories
Thermo Fisher Scientific
SK pharmteco
Batavia Biosciences
HALIX
Catalent Biologics
Oxford BioMedica
Biovian
Viral Vector CTDMO Services Segment by Type
Adeno-associated Viral
Adenoviral
Lentiviral
Retroviral
Viral Vector CTDMO Services Segment by Application
Gene Therapy
Cell Therapy
Vaccine Development
Viral Vector CTDMO Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Vector CTDMO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Viral Vector CTDMO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Vector CTDMO Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Viral Vector CTDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Viral Vector CTDMO Services industry.
Chapter 3: Detailed analysis of Viral Vector CTDMO Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Viral Vector CTDMO Servicesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Adeno-associated Viral
- Adenoviral
- Lentiviral
- Retroviral
Applications
- Gene Therapy
- Cell Therapy
- Vaccine Development
Companies covered
- AGC Biologics
- Lonza
- Charles River Laboratories
- Thermo Fisher Scientific
- SK pharmteco
- Batavia Biosciences
- HALIX
- Catalent Biologics
- Oxford BioMedica
- Biovian
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Viral Vector CTDMO Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Adeno-associated Viral
- 1.2.3 Adenoviral
- 1.2.4 Lentiviral
- 1.2.5 Retroviral
- 1.3 Market Analysis by Application
- 1.3.1 Global Viral Vector CTDMO Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Gene Therapy
- 1.3.3 Cell Therapy
- 1.3.4 Vaccine Development
- 1.4 Global Market Growth Prospects
- 1.5 Global Viral Vector CTDMO Services Growth Trends by Region
- 1.5.1 Global Viral Vector CTDMO Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Viral Vector CTDMO Services Market Size by Region (2021-2026)
- 1.5.3 Viral Vector CTDMO Services Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Viral Vector CTDMO Services Market Dynamics
- 2.1 Viral Vector CTDMO Services Industry Trends
- 2.2 Viral Vector CTDMO Services Industry Drivers
- 2.3 Viral Vector CTDMO Services Industry Opportunities and Challenges
- 2.4 Viral Vector CTDMO Services Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Viral Vector CTDMO Services Revenue by Company (2021-2026)
- 3.2 Global Viral Vector CTDMO Services Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Viral Vector CTDMO Services Key Company Head office and Area Served
- 3.4 Global Viral Vector CTDMO Services Company, Product Type & Application
- 3.5 Global Viral Vector CTDMO Services Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Viral Vector CTDMO Services Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Viral Vector CTDMO Services Players Market Share by Revenue in 2025
- 3.6.3 2025 Viral Vector CTDMO Services Tier 1, Tier 2, and Tier 3
4 Viral Vector CTDMO Services Market by Type
- 4.1 Global Viral Vector CTDMO Services Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Viral Vector CTDMO Services Market Size by Type (2021-2032)
- 4.3 Global Viral Vector CTDMO Services Market Size Share by Type (2021-2032)
5 Viral Vector CTDMO Services Market by Application
- 5.1 Global Viral Vector CTDMO Services Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Viral Vector CTDMO Services Market Size by Application (2021-2032)
- 5.3 Global Viral Vector CTDMO Services Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AGC Biologics
- 6.1.1 AGC Biologics Company Information
- 6.1.2 AGC Biologics Business Overview
- 6.1.3 AGC Biologics Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AGC Biologics Viral Vector CTDMO Services Product Portfolio
- 6.1.5 AGC Biologics Recent Developments
- 6.2 Lonza
- 6.2.1 Lonza Company Information
- 6.2.2 Lonza Business Overview
- 6.2.3 Lonza Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Lonza Viral Vector CTDMO Services Product Portfolio
- 6.2.5 Lonza Recent Developments
- 6.3 Charles River Laboratories
- 6.3.1 Charles River Laboratories Company Information
- 6.3.2 Charles River Laboratories Business Overview
- 6.3.3 Charles River Laboratories Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Charles River Laboratories Viral Vector CTDMO Services Product Portfolio
- 6.3.5 Charles River Laboratories Recent Developments
- 6.4 Thermo Fisher Scientific
- 6.4.1 Thermo Fisher Scientific Company Information
- 6.4.2 Thermo Fisher Scientific Business Overview
- 6.4.3 Thermo Fisher Scientific Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Thermo Fisher Scientific Viral Vector CTDMO Services Product Portfolio
- 6.4.5 Thermo Fisher Scientific Recent Developments
- 6.5 SK pharmteco
- 6.5.1 SK pharmteco Company Information
- 6.5.2 SK pharmteco Business Overview
- 6.5.3 SK pharmteco Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 SK pharmteco Viral Vector CTDMO Services Product Portfolio
- 6.5.5 SK pharmteco Recent Developments
- 6.6 Batavia Biosciences
- 6.6.1 Batavia Biosciences Company Information
- 6.6.2 Batavia Biosciences Business Overview
- 6.6.3 Batavia Biosciences Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Batavia Biosciences Viral Vector CTDMO Services Product Portfolio
- 6.6.5 Batavia Biosciences Recent Developments
- 6.7 HALIX
- 6.7.1 HALIX Company Information
- 6.7.2 HALIX Business Overview
- 6.7.3 HALIX Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 HALIX Viral Vector CTDMO Services Product Portfolio
- 6.7.5 HALIX Recent Developments
- 6.8 Catalent Biologics
- 6.8.1 Catalent Biologics Company Information
- 6.8.2 Catalent Biologics Business Overview
- 6.8.3 Catalent Biologics Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Catalent Biologics Viral Vector CTDMO Services Product Portfolio
- 6.8.5 Catalent Biologics Recent Developments
- 6.9 Oxford BioMedica
- 6.9.1 Oxford BioMedica Company Information
- 6.9.2 Oxford BioMedica Business Overview
- 6.9.3 Oxford BioMedica Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Oxford BioMedica Viral Vector CTDMO Services Product Portfolio
- 6.9.5 Oxford BioMedica Recent Developments
- 6.10 Biovian
- 6.10.1 Biovian Company Information
- 6.10.2 Biovian Business Overview
- 6.10.3 Biovian Viral Vector CTDMO Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Biovian Viral Vector CTDMO Services Product Portfolio
- 6.10.5 Biovian Recent Developments
7 North America
- 7.1 North America Viral Vector CTDMO Services Market Size (2021-2032)
- 7.2 North America Viral Vector CTDMO Services Market Size by Type
- 7.2.1 North America Viral Vector CTDMO Services Market Size by Type (2021-2026)
- 7.2.2 North America Viral Vector CTDMO Services Market Size by Type (2027-2032)
- 7.2.3 North America Viral Vector CTDMO Services Market Share by Type (2021-2032)
- 7.3 North America Viral Vector CTDMO Services Market Size by Application
- 7.3.1 North America Viral Vector CTDMO Services Market Size by Application (2021-2026)
- 7.3.2 North America Viral Vector CTDMO Services Market Size by Application (2027-2032)
- 7.3.3 North America Viral Vector CTDMO Services Market Share by Application (2021-2032)
- 7.4 North America Viral Vector CTDMO Services Market Size by Country
- 7.4.1 North America Viral Vector CTDMO Services Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 7.4.3 North America Viral Vector CTDMO Services Market Size by Country (2027-2032)
- 7.4.4 North America Viral Vector CTDMO Services Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Viral Vector CTDMO Services Market Size (2021-2032)
- 8.2 Europe Viral Vector CTDMO Services Market Size by Type
- 8.2.1 Europe Viral Vector CTDMO Services Market Size by Type (2021-2026)
- 8.2.2 Europe Viral Vector CTDMO Services Market Size by Type (2027-2032)
- 8.2.3 Europe Viral Vector CTDMO Services Market Share by Type (2021-2032)
- 8.3 Europe Viral Vector CTDMO Services Market Size by Application
- 8.3.1 Europe Viral Vector CTDMO Services Market Size by Application (2021-2026)
- 8.3.2 Europe Viral Vector CTDMO Services Market Size by Application (2027-2032)
- 8.3.3 Europe Viral Vector CTDMO Services Market Share by Application (2021-2032)
- 8.4 Europe Viral Vector CTDMO Services Market Size by Country
- 8.4.1 Europe Viral Vector CTDMO Services Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 8.4.3 Europe Viral Vector CTDMO Services Market Size by Country (2027-2032)
- 8.4.4 Europe Viral Vector CTDMO Services Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Viral Vector CTDMO Services Market Size (2021-2032)
- 9.2 China Viral Vector CTDMO Services Market Size by Type
- 9.2.1 China Viral Vector CTDMO Services Market Size by Type (2021-2026)
- 9.2.2 China Viral Vector CTDMO Services Market Size by Type (2027-2032)
- 9.2.3 China Viral Vector CTDMO Services Market Share by Type (2021-2032)
- 9.3 China Viral Vector CTDMO Services Market Size by Application
- 9.3.1 China Viral Vector CTDMO Services Market Size by Application (2021-2026)
- 9.3.2 China Viral Vector CTDMO Services Market Size by Application (2027-2032)
- 9.3.3 China Viral Vector CTDMO Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Viral Vector CTDMO Services Market Size (2021-2032)
- 10.2 Asia Viral Vector CTDMO Services Market Size by Type
- 10.2.1 Asia Viral Vector CTDMO Services Market Size by Type (2021-2026)
- 10.2.2 Asia Viral Vector CTDMO Services Market Size by Type (2027-2032)
- 10.2.3 Asia Viral Vector CTDMO Services Market Share by Type (2021-2032)
- 10.3 Asia Viral Vector CTDMO Services Market Size by Application
- 10.3.1 Asia Viral Vector CTDMO Services Market Size by Application (2021-2026)
- 10.3.2 Asia Viral Vector CTDMO Services Market Size by Application (2027-2032)
- 10.3.3 Asia Viral Vector CTDMO Services Market Share by Application (2021-2032)
- 10.4 Asia Viral Vector CTDMO Services Market Size by Country
- 10.4.1 Asia Viral Vector CTDMO Services Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 10.4.3 Asia Viral Vector CTDMO Services Market Size by Country (2027-2032)
- 10.4.4 Asia Viral Vector CTDMO Services Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Viral Vector CTDMO Services Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Type
- 11.2.1 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Viral Vector CTDMO Services Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Application
- 11.3.1 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Viral Vector CTDMO Services Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Country
- 11.4.1 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Viral Vector CTDMO Services Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Viral Vector CTDMO Services Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst